DE HB24 | 2019-2020 | 150th General Assembly
Status
Completed Legislative Action
Spectrum: Slight Partisan Bill (Democrat 12-5)
Status: Passed on June 19 2019 - 100% progression
Action: 2019-06-19 - Signed by Governor
Text: Latest bill text (Engrossed) [HTML]
Spectrum: Slight Partisan Bill (Democrat 12-5)
Status: Passed on June 19 2019 - 100% progression
Action: 2019-06-19 - Signed by Governor
Text: Latest bill text (Engrossed) [HTML]
Summary
This Act would prohibit insurers and pharmacy benefit managers from engaging in the practice of "clawbacks". When the total cost of a prescription drug to an insurer or pharmacy benefits manager is less than a patient's co-pay, the insurer or pharmacy benefits manager keeps the difference in a practice known as a "clawback".
Title
An Act To Amend Title 18 Of The Delaware Code Relating To Copayment Or Coinsurance For Prescription Drugs.
Sponsors
Roll Calls
2019-06-12 - Senate - Senate Third Reading (Y: 18 N: 0 NV: 0 Abs: 3) [PASS]
2019-03-21 - House - House Third Reading (Y: 38 N: 0 NV: 0 Abs: 3) [PASS]
2019-03-21 - House - House Third Reading (Y: 38 N: 0 NV: 0 Abs: 3) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2019-06-19 | Signed by Governor | |
| 2019-06-12 | Passed By Senate. Votes: 18 YES 3 ABSENT | |
| 2019-04-17 | Reported Out of Committee (Health & Social Services) in Senate with 5 On Its Merits | |
| 2019-03-26 | Assigned to Health & Social Services Committee in Senate | |
| 2019-03-21 | Passed By House. Votes: 38 YES 3 ABSENT | |
| 2019-03-21 | Amendment HA 1 to HB 24 - Passed In House by Voice Vote | |
| 2019-03-14 | Amendment HA 1 to HB 24 - Introduced and Placed With Bill | |
| 2019-01-23 | Reported Out of Committee (Economic Development/Banking/Insurance & Commerce) in House with 3 Favorable, 9 On Its Merits | |
| 2019-01-04 | Introduced and Assigned to Economic Development/Banking/Insurance/Commerce Committee in House |
